Sands Frank M.
- SEC CIK
- 0001870494
In the past year, 1 open-market purchase filing worth $3.00M and no sales.
Current role at each company
- IKT Inhibikase Therapeutics, Inc.10% Owneras of Nov 24, 2025
- ABOS Acumen Pharmaceuticals, Inc.10% Owneras of Jul 8, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $3.00M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$3.00M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sands Frank M. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IKT Inhibikase Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2025 (view filing)3:47 PM ET | Nov 21 | 3 days | Sands Capital Alternatives, LLC and 2 others10% Owner | PPurchase | +2.07M | $1.45 | +$3.00M | +18.9%13.0M after |
ABOS Acumen Pharmaceuticals, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 8, 2021 (view filing)5:21 PM ET | Jul 6 | 2 days | Sands Capital Life Sciences Pulse Fund, LLC and 3 others10% Owner | PPurchase | +450.0K | $14.88 | +$6.70M | +15.2%3.42M after |